Search Within

Jennifer Lynn Sauter

Formats
  1. Journal Article (59)
  2. Meeting Abstract (56)
  3. Review (4)
  4. Guidelines (3)
  5. Correspondence (2)
Groups
  1. Department of Pathology and Laboratory Medicine (124)
  2. Department of Medicine (83)
  3. Solid Tumor Oncology Division (80)
  4. Thoracic Oncology (80)
  5. GSK Faculty (64)
  6. Surgery (61)

More Groups

People
  1. William Travis (71)
  2. Natasha Rekhtman (53)
  3. Marc Ladanyi (41)
  4. Jason Chang (40)
  5. Marjorie Zauderer (39)
  6. Prasad Adusumilli (35)

More People

Years
  1. 2025 (5)
  2. 2024 (17)
  3. 2023 (7)
  4. 2022 (14)
  5. 2021 (18)
  6. 2020 (24)

More Years

Publications
  1. Journal of Thoracic Oncology (25)
  2. Modern Pathology (23)
  3. Laboratory Investigation (19)
  4. Journal of Clinical Oncology (13)
  5. Clinical Cancer Research (5)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (29)
  2. Nature Research (24)
  3. Nature Publishing Group (19)
  4. American Society of Clinical Oncology (13)
  5. American Association for Cancer Research (12)
  6. Oxford University Press (5)

More Publishers

Results (124)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular correlates of PD-L1 expression in patients with non-small cell lung cancer
    Meeting Abstract

    Rizvi, H.; Bandlamudi, C.; Schoenfeld, A. J.; Sauter, J. L.; Arbour, K. C.; Beras, A.; Egger, J. V.; Ladanyi, M.; Donoghue, M.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes to first-line pembrolizumab in patients with non-small cell lung cancer and a PD-L1 tumor proportion score ≥90%
    Meeting Abstract

    Jimenez Aguilar, E.; Ricciuti, B.; Gainor, J. F.; Nishino, M.; Adeni, A. E.; Subegdjo, S.; Khosrowjerdi, S.; Peterson, R.; Digumarthy, S.; Liu, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Prevalence and preliminary validation of screening criteria to identify carriers of germline BAP1 mutations
    Journal Article

    Zauderer, M. G.; Jayakumaran, G.; DuBoff, M.; Zhang, L.; Francis, J. H.; Abramson, D. H.; Cercek, A.; Nash, G. M.; Shoushtari, A.; Chapman, P.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Pericardial mesothelioma: A multi-institutional study of 61 cases
    Meeting Abstract

    Ortiz-Villalón, C.; Le Stang, N.; Salle, F. G.; Hiroshima, K.; Maleszewski, J.; Roden, A.; Travis, W.; Chapel, D.; Ekman, S.; Husain, A.; more...
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Evaluation of H3K27me3 expression as a marker of EZH2 activation in SMARCA4/SMARCA2-deficient tumors and candidate biomarker for trials of EZH2 inhibitors
    Meeting Abstract

    Kezlarian, B.; Montecalvo, J.; Sauter, J.; Travis, W.; Gounder, M.; Rudin, C.; Ladanyi, M.; Namakydoust, A.; Rekhtman, N.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Acute lung injury pattern is a frequent histologic finding in lung tissue following immune checkpoint inhibitor therapy
    Meeting Abstract

    Golden, A.; Imran, S.; Feinstein, M.; Hellmann, M.; Plodkowski, A.; Rekhtman, N.; Rizvi, H.; Travis, W.; Stover, D.; Sauter, J.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Assessment of the Bethesda System for Reporting Thyroid Cytopathology: Surgical and long-term clinical follow-up of 2,893 thyroid fine-needle aspirations
    Journal Article

    Sauter, J. L.; Lehrke, H.; Zhang, X.; Al Badri, O. T.; Rodriguez-Gutierrez, R.; Delivanis, D. A.; Singh Ospina, N.; Donegan, D.; Hamidi, O.; Iñiguez-Ariza, N.; more...
    American Journal of Clinical Pathology (2019)

    Fulltext@MSK | Save
  • Pericardial mesothelioma: A multi-institutional study of 61 cases
    Meeting Abstract

    Ortiz-Villalón, C.; Le Stang, N.; Salle, F. G.; Hiroshima, K.; Maleszewski, J.; Roden, A.; Travis, W.; Chapel, D.; Ekman, S.; Husain, A.; more...
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Evaluation of H3K27me3 expression as a marker of EZH2 activation in SMARCA4/SMARCA2-deficient tumors and candidate biomarker for trials of EZH2 inhibitors
    Meeting Abstract

    Kezlarian, B.; Montecalvo, J.; Sauter, J.; Travis, W.; Gounder, M.; Rudin, C.; Ladanyi, M.; Namakydoust, A.; Rekhtman, N.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Acute lung injury pattern is a frequent histologic finding in lung tissue following immune checkpoint inhibitor therapy
    Meeting Abstract

    Golden, A.; Imran, S.; Feinstein, M.; Hellmann, M.; Plodkowski, A.; Rekhtman, N.; Rizvi, H.; Travis, W.; Stover, D.; Sauter, J.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save